# Apollo Global Management, Inc.: financial statements, quarterly

APO · NYSE · CIK 1858681 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/apo.md) · [Financials](/companies/apo/financials.md) · [Filings](/companies/apo/filings.md) · [Insiders](/companies/apo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/apo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [2.6](/filings/0001858681-24-000120.md) | [11.0 d](/filings/0001858681-26-000013.md) | [7.0](/filings/0001858681-25-000049.md) | [6.0](/filings/0001858681-25-000117.md) | [7.8](/filings/0001858681-25-000139.md) | [5.3 d](/filings/0001858681-26-000013.md) | [5.5](/filings/0001858681-26-000026.md) | [6.8](/filings/0001858681-26-000040.md) | [9.8](/filings/0001858681-25-000139.md) | [9.9 d](/filings/0001858681-26-000013.md) | [5.1](/filings/0001858681-26-000026.md) | [11.2](/filings/0001858681-26-000040.md) |
| Income tax | $bn | [0.2](/filings/0001858681-24-000120.md) | [(1.6) d](/filings/0001858681-26-000013.md) | [0.4](/filings/0001858681-25-000049.md) | [0.3](/filings/0001858681-25-000117.md) | [0.3](/filings/0001858681-25-000139.md) | [0.1 d](/filings/0001858681-26-000013.md) | [0.2](/filings/0001858681-26-000026.md) | [0.0](/filings/0001858681-26-000040.md) | [0.4](/filings/0001858681-25-000139.md) | [0.6 d](/filings/0001858681-26-000013.md) | [1.7](/filings/0001858681-26-000026.md) | [0.4](/filings/0001858681-26-000040.md) |
| Net income | $bn | [0.7](/filings/0001858681-24-000120.md) | [2.8 d](/filings/0001858681-26-000013.md) | [1.4](/filings/0001858681-25-000049.md) | [0.9](/filings/0001858681-25-000117.md) | [0.8](/filings/0001858681-25-000139.md) | [1.5 d](/filings/0001858681-26-000013.md) | [0.4](/filings/0001858681-26-000026.md) | [0.6](/filings/0001858681-26-000040.md) | [1.7](/filings/0001858681-25-000139.md) | [0.7 d](/filings/0001858681-26-000013.md) | [(1.9)](/filings/0001858681-26-000026.md) | [1.4](/filings/0001858681-26-000040.md) |
| Diluted EPS | $ per share | [1.10](/filings/0001858681-24-000120.md) | not reported | [2.28](/filings/0001858681-25-000049.md) | [1.35](/filings/0001858681-25-000117.md) | [1.29](/filings/0001858681-25-000139.md) | not reported | [0.68](/filings/0001858681-26-000026.md) | [0.99](/filings/0001858681-26-000040.md) | [2.78](/filings/0001858681-25-000139.md) | not reported | [(3.27)](/filings/0001858681-26-000026.md) | [2.15](/filings/0001858681-26-000040.md) |
| Basic EPS | $ per share | [1.10](/filings/0001858681-24-000120.md) | not reported | [2.31](/filings/0001858681-25-000049.md) | [1.36](/filings/0001858681-25-000117.md) | [1.30](/filings/0001858681-25-000139.md) | not reported | [0.68](/filings/0001858681-26-000026.md) | [1.00](/filings/0001858681-26-000040.md) | [2.82](/filings/0001858681-25-000139.md) | not reported | [(3.27)](/filings/0001858681-26-000026.md) | [2.18](/filings/0001858681-26-000040.md) |

- Revenue: us-gaap:Revenues
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [283](/filings/0001858681-23-000042.md) | [313](/filings/0001858681-25-000034.md) | [334](/filings/0001858681-24-000048.md) | [347](/filings/0001858681-24-000096.md) | [369](/filings/0001858681-24-000120.md) | [378](/filings/0001858681-26-000013.md) | [395](/filings/0001858681-25-000049.md) | [420](/filings/0001858681-25-000117.md) | [450](/filings/0001858681-25-000139.md) | [461](/filings/0001858681-26-000040.md) | [468](/filings/0001858681-26-000026.md) | [494](/filings/0001858681-26-000040.md) |
| Total liabilities | $bn | [265](/filings/0001858681-23-000042.md) | [288](/filings/0001858681-25-000034.md) | [307](/filings/0001858681-24-000048.md) | [318](/filings/0001858681-24-000096.md) | [337](/filings/0001858681-24-000120.md) | [347](/filings/0001858681-26-000013.md) | [363](/filings/0001858681-25-000049.md) | [386](/filings/0001858681-25-000117.md) | [410](/filings/0001858681-25-000139.md) | [418](/filings/0001858681-26-000040.md) | [428](/filings/0001858681-26-000026.md) | [453](/filings/0001858681-26-000040.md) |
| Long-term debt | $bn | [7.0](/filings/0001858681-23-000042.md) | [8.1](/filings/0001858681-25-000034.md) | [9.6](/filings/0001858681-24-000048.md) | [9.8](/filings/0001858681-24-000096.md) | [9.8](/filings/0001858681-24-000120.md) | [10.6](/filings/0001858681-26-000013.md) | [10.6](/filings/0001858681-25-000049.md) | [12.1](/filings/0001858681-25-000117.md) | [12.6](/filings/0001858681-25-000139.md) | [13.4](/filings/0001858681-26-000040.md) | [14.2](/filings/0001858681-26-000026.md) | [13.7](/filings/0001858681-26-000040.md) |
| Shareholders' equity | $bn | [8.4](/filings/0001858681-23-000042.md) | [14.0](/filings/0001858681-25-000034.md) | [14.8](/filings/0001858681-24-000048.md) | [15.3](/filings/0001858681-24-000096.md) | [17.9](/filings/0001858681-24-000120.md) | [17.3](/filings/0001858681-26-000013.md) | [18.0](/filings/0001858681-25-000049.md) | [19.3](/filings/0001858681-25-000117.md) | [23.1](/filings/0001858681-25-000139.md) | [23.3](/filings/0001858681-26-000040.md) | [20.0](/filings/0001858681-26-000026.md) | [21.0](/filings/0001858681-26-000040.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(364) d](/filings/0001858681-24-000120.md) | [2,064 d](/filings/0001858681-26-000013.md) | [70.0](/filings/0001858681-25-000049.md) | [1,333 d](/filings/0001858681-25-000117.md) | [1,854 d](/filings/0001858681-25-000139.md) | [(4.0) d](/filings/0001858681-26-000013.md) | [1,012](/filings/0001858681-26-000026.md) | [1,262 d](/filings/0001858681-26-000040.md) | [303 d](/filings/0001858681-25-000139.md) | [4,669 d](/filings/0001858681-26-000013.md) | [1,620](/filings/0001858681-26-000026.md) | [2,881 d](/filings/0001858681-26-000040.md) |
| Dividends paid | $m | [256 d](/filings/0001858681-24-000120.md) | [259 d](/filings/0001858681-26-000013.md) | [259](/filings/0001858681-25-000049.md) | [279 d](/filings/0001858681-25-000117.md) | [277 d](/filings/0001858681-25-000139.md) | [277 d](/filings/0001858681-26-000013.md) | [278](/filings/0001858681-26-000026.md) | [306 d](/filings/0001858681-26-000040.md) | [306 d](/filings/0001858681-25-000139.md) | [311 d](/filings/0001858681-26-000013.md) | [312](/filings/0001858681-26-000026.md) | [342 d](/filings/0001858681-26-000040.md) |
| Share repurchases | $m | [0.0 d](/filings/0001858681-24-000120.md) | [26.0 d](/filings/0001858681-26-000013.md) | [260](/filings/0001858681-25-000049.md) | [75.0 d](/filings/0001858681-25-000117.md) | [453 d](/filings/0001858681-25-000139.md) | [102 d](/filings/0001858681-26-000013.md) | [193](/filings/0001858681-26-000026.md) | [0.0 d](/filings/0001858681-26-000040.md) | [340 d](/filings/0001858681-25-000139.md) | [240 d](/filings/0001858681-26-000013.md) | [632](/filings/0001858681-26-000026.md) | [97.0 d](/filings/0001858681-26-000040.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [584](/filings/0001858681-23-000042.md) | [584](/filings/0001858681-24-000048.md) | [579](/filings/0001858681-24-000096.md) | [579](/filings/0001858681-24-000120.md) | [605](/filings/0001858681-25-000049.md) | [590](/filings/0001858681-25-000117.md) | [589](/filings/0001858681-25-000139.md) | [593](/filings/0001858681-26-000026.md) | [590](/filings/0001858681-26-000040.md) | [608](/filings/0001858681-25-000139.md) | [595](/filings/0001858681-26-000026.md) | [610](/filings/0001858681-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 590,543,159 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001858681-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.